Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 104 results found. Search for [ essential drugs ]

Results 40 to 60 of 104
E Kumar Sharma
June 29, 2015
Over the years, policy formulators within the government seem to have figured out the ailments affecting the Indian pharma industry and at regular intervals, have responded with antidotes.

Zeba Siddiqui
Mumbai, June 11, 2015
More than a third of India's 2.1 million HIV/AIDS patients depend on getting their daily antiretrovirals for free from state-run distribution centres.

E. Kumar Sharma
May 28, 2015
While the Union Finance Minister Arun Jaitley in his Budget speech this year said he proposed \"to work towards creating a universal social security system for all Indians\", the fact remains that India still continues to lag peers on healthcare.

Mail Today Bureau
New Delhi, April 21, 2015
The Standing Committee on Chemicals and Fertilisers has recommended bringing all medicines sold in the country under price control.

New Delhi, April 8, 2015
The government has allowed pharmaceutical companies to hike rates of 509 essential medicines used for treating various ailments like diabetes, hepatitis and cancer by 3.84 per cent with effect from April 1.

Zeba Siddiqui
Mumbai, April 2, 2015
The drugs likely to be included in the list of nearly 400 essential drugs are part of the government's HIV/AIDS and tuberculosis control programmes.

E Kumar Sharma
March 30, 2015
Union Minister of State for Chemicals & Fertilisers Hansraj Gangaram Ahir has announced a Rs 900-crore revival package for IDPL, which has almost come to a standstill in terms of operations.

New Delhi, March 19, 2015
The government has exempted drugs and pharmaceuticals from the the levy of Education Cess and Secondary and Higher Education Cess, resulting into reduction of excise duty from 6.18 per cent to 6 per cent.

New Delhi, March 3, 2015
Out of 509 drugs, above 40 per cent price reduction has happened in the case of 127 essential medicines, while prices of 34 drugs has come down in the range of 35-40 per cent,

Ajay Tyagi & Munish Shekhavat
New Delhi, December 26, 2014
The government sought to put controls on drugmakers when it came to pricing of essential drugs, including those for common cough and cold as also for cancer and other diseases.

E Kumar Sharma
December 24, 2014
Sun Pharmaceutical's move to acquire Ranbaxy is arguably the high point of 2014 for the pharmaceutical sector.

Zeba Siddiqui
Mumbai, December 12, 2014
Besides commonly-used antibiotics and pain-killers, the new drugs to come under price control include medicines used for treating cancer and skin disorders.

E Kumar Sharma
December 6, 2014
\"We are clearly disappointed by the outcome and do feel it raises questions on the future viability of this business,\" Manni Kantipudi, CEO of GVK Biosciences told.

New Delhi, December 2, 2014
The government in considering the free essential drugs scheme in a bid to bring down out-of-pocket expenditure of an individual on health care.

Sanjeev Jha
November 17, 2014
From a business model innovation perspective, I believe the companies need to leverage both their wealth of experience and market realities.

Aditya Kalra
Mumbai, October 30, 2014
Under the National Health Assurance Mission, Prime Minister Narendra Modi's government would provide all citizens with free drugs and diagnostic treatment, as well as insurance cover to treat serious ailments.

Mumbai, October 13, 2014
The Swiss drugmaker, which did not confirm the quantum of the total penalty by the the National Pharmaceutical Pricing Authority (NPPA), said the notice is \"erroneous and entirely misconceived\".

E Kumar Sharma
September 24, 2014
\"This is for the first time, I think, that a pharma policy has been rolled back... It is a very positive move,\" Biocon Chairperson and MD Kiran Mazumdar-Shaw said.

Zeba Siddiqui
Mumbai, September 23, 2014
The government has withdrawn guidelines issued on May 29 that gave the drug pricing regulator power to fix prices of drugs deemed non-essential.

Mail Today Bureau
New Delhi, September 20, 2014
Major drug companies, including Cipla, Ranbaxy, Lupin and Cadila, are likely to be impacted by the decision.

PAGES 3 OF 6  12345